Search Results - "Seiz, Pia"
-
1
Combination of DNA prime--adenovirus boost immunization with entecavir elicits sustained control of chronic hepatitis B in the woodchuck model
Published in PLoS pathogens (01-06-2013)“…A potent therapeutic T-cell vaccine may be an alternative treatment of chronic hepatitis B virus (HBV) infection. Previously, we developed a DNA…”
Get full text
Journal Article -
2
Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection
Published in PLoS pathogens (01-01-2014)“…Hepatitis B virus (HBV) persistence is facilitated by exhaustion of CD8 T cells that express the inhibitory receptor programmed cell death-1 (PD-1)…”
Get full text
Journal Article -
3
New broadly reactive neutralizing antibodies against hepatitis B virus surface antigen
Published in Virus research (04-01-2016)“…•Neutralizing MAb HB1 specific to HbsAg “a” determinant was developed and characterized.•The MAb HB1 recognizes a conserved linear HBsAg epitope…”
Get full text
Journal Article -
4
Studies of nosocomial outbreaks of hepatitis B in nursing homes in Germany suggest a major role of hepatitis B e antigen expression in disease severity and progression
Published in International journal of medical microbiology (01-10-2015)“…Abstract Hepatitis B virus (HBV) causes acute or chronic hepatitis B. Local outbreaks of HBV infections in skilled nursing facilities is a matter of growing…”
Get full text
Journal Article -
5
Entecavir allows an unexpectedly high residual replication of HBV mutants resistant to lamivudine
Published in Antiviral therapy (01-01-2015)“…Entecavir is an efficient inhibitor of HBV reverse transcriptase (RT) and widely used for therapy of chronic hepatitis B. Entecavir treatment of HBV patients…”
Get more information
Journal Article -
6
Characterization of the 3rd International Standard for hepatitis B virus surface antigen (HBsAg)
Published in Journal of clinical virology (01-09-2016)“…Highlights • Overall the 3rd HBsAg International Standard (IS) is very similar to the 2nd IS. • The 2nd IS with HBV subgenotype A2, HBsAg subtype adw2 was from…”
Get full text
Journal Article -
7
International collaborative study on the 3rd WHO International Standard for hepatitis B surface antigen
Published in Journal of clinical virology (01-09-2016)“…Highlights • The WHO International Standard (IS) for hepatitis B surface antigen (HBsAg) is used to standardize HBsAg assays. • A WHO international…”
Get full text
Journal Article -
8
Enhancing Virus-Specific Immunity In Vivo by Combining Therapeutic Vaccination and PD-L1 Blockade in Chronic Hepadnaviral Infection: e1003856
Published in PLoS pathogens (01-01-2014)“…Hepatitis B virus (HBV) persistence is facilitated by exhaustion of CD8 T cells that express the inhibitory receptor programmed cell death-1 (PD-1)…”
Get full text
Journal Article -
9
Combination of DNA Prime - Adenovirus Boost Immunization with Entecavir Elicits Sustained Control of Chronic Hepatitis B in the Woodchuck Model: e1003391
Published in PLoS pathogens (01-06-2013)“…A potent therapeutic T-cell vaccine may be an alternative treatment of chronic hepatitis B virus (HBV) infection. Previously, we developed a DNA…”
Get full text
Journal Article